ESC 365 - Treating HFpEF: State of the art 2022

ESC Professional Premium Access

Treating HFpEF: State of the art 2022

Session: How to treat HFpEF in 2022 and beyond

Topic: Chronic Heart Failure

Speaker: Professor S. Solomon (Boston, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

3 more presentations in this session

Efficacy of empagliflozin in patients with heart failure according to baseline KDIGO risk categories - findings from the EMPEROR-Pooled

Speaker: Professor J. Butler (Dallas, US)

Efficacy and safety of sacubitril/valsartan according to frailty in heart failure with preserved ejection fraction: a post hoc analysis of the PARAGON-HF trial

Speaker: Doctor J. Butt (Copenhagen, DK)

Digoxin improves systolic cardiac function in patients with AF and HFpEF: the RATE-AF randomised trial

Speaker: Doctor K. Bunting (Birmingham, GB)

Access the full session

How to treat HFpEF in 2022 and beyond

Speakers: Professor S. Solomon, Professor J. Butler, Doctor J. Butt, Doctor K. Bunting

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources